Kriti PatelPolaroid Therapeutics, a Swiss-based biotech start-up, has achieved significant pre-clinical milestones in the development of its antimicrobial polymer technology for the treatment of acute and chronic wounds. The company’s polymer technology disrupts bacterial cells without triggering antimicrobial resistance, a top global public health threat. Polaroid Therapeutics aims to collaborate with industry leaders in advanced wound care to develop superior healthcare products and improve patient outcomes.
Polaroid Therapeutics conquers milestones in antimicrobial tech for wounds.
Latest from News
Unlock 14% CAGR over 5 years with Jiangnan Mould & Plastic Technology
TLDR: Jiangnan Mould & Plastic Technology (SZSE:000700) has delivered a 14% compound annual growth rate to shareholders over the past 5 years. The stock
Elon Musk drops chatbot code in escalating A.I. warfare
Elon Musk Opens Up Grok Chatbot Code – Article Summary TLDR: Elon Musk released the raw computer code behind Grok, an A.I. chatbot designed
Introducing ‘The Genius Wave’: A Complete Review of Cutting-Edge Tech
TLDR: ‘The Genius Wave’ is a revolutionary product redefining technology interaction It offers advanced technology, user-friendly interface, versatility, and future readiness Unveiling ‘The Genius
PAR Technology Director Rauch sells one-third stake in company holdings.
TLDR: PAR Technology Corporation’s Independent Director, Douglas Rauch, sold 33% of his holding for US$189k at US$42.04 per share. Rauch’s sale is the largest
Paralyzed voices find freedom with new AI talk software.
TLDR: Researchers at UCLA have developed a wearable, adhesive device using AI technology to help people with paralyzed vocal cords regain their voice function.